Gerard Rabbette Sells 43,355 Shares of Uniphar (LON:UPR) Stock

Uniphar plc (LON:UPRGet Free Report) insider Gerard Rabbette sold 43,355 shares of Uniphar stock in a transaction that occurred on Wednesday, December 10th. The shares were sold at an average price of GBX 362, for a total transaction of £156,945.10.

Uniphar Stock Down 1.6%

LON UPR opened at GBX 310 on Friday. The stock has a market capitalization of £804.68 million, a PE ratio of 12.65 and a beta of 0.75. The company has a debt-to-equity ratio of 119.48, a current ratio of 0.90 and a quick ratio of 0.60. Uniphar plc has a fifty-two week low of GBX 163 and a fifty-two week high of GBX 368. The business has a fifty day moving average price of GBX 330.76 and a two-hundred day moving average price of GBX 330.85.

Wall Street Analyst Weigh In

Separately, Royal Bank Of Canada upped their price target on shares of Uniphar from GBX 470 to GBX 480 and gave the stock an “outperform” rating in a research report on Tuesday, September 9th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 427.50.

Read Our Latest Analysis on UPR

Uniphar Company Profile

(Get Free Report)

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology
manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.

Read More

Receive News & Ratings for Uniphar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uniphar and related companies with MarketBeat.com's FREE daily email newsletter.